Kalkulator od Bio Protocol do Euro
Lako pretvorite Bio Protocol u Euro s našim kalkulatorom. Upoznajte evoluciju konverzije i glavne ekvivalencije između BIO i EUR.
Konverter kriptovaluta
Bio Protocol u EUR — Tržišni podaci
Tržišna kapitalizacija
58,71 mil.€
24h volumen
25,58 mil.€
Maksimalna ponuda
3,32 mlr.
Ponuda u optjecaju
3,32 mlr.
Tip
currency
Cijena od BIO/EUR - Bio Protocol/Euro
Cijena Bio Protocol je povećava se
Vrijednost Bio Protocol je 0,0273€. To znači, za kupnju 5 BIO, trebate platiti 0,1366€. S druge strane, s 1,00€ možete kupiti ukupno 36,58982803 BIO, dok bi 50,00€ omogućio kupnju 1.829,49140139 BIO.
U posljednjih 7 dana, cijena Bio Protocol je povećano za +10,88%. Dok je u posljednjih 24 sata cijena promijenjena za +8,19%.
Konverzija BIO u EUR
| Količina | 12. 06. 2026. 02:13 |
|---|---|
| 0.5 BIO | 0,0137€ |
| 1 BIO | 0,0273€ |
| 2 BIO | 0,0547€ |
| 5 BIO | 0,1366€ |
| 10 BIO | 0,2733€ |
| 50 BIO | 1,37€ |
| 100 BIO | 2,73€ |
| 500 BIO | 13,67€ |
| 1000 BIO | 27,33€ |
Konverzija EUR u BIO
| Količina | 12. 06. 2026. 02:13 |
|---|---|
| 0,5000€ | 0.01366500 BIO |
| 1,00€ | 0.02733000 BIO |
| 2,00€ | 0.05466000 BIO |
| 5,00€ | 0.13665000 BIO |
| 10,00€ | 0.27330000 BIO |
| 50,00€ | 1.36650000 BIO |
| 100,00€ | 2.73300000 BIO |
| 500,00€ | 13.66500000 BIO |
| 1.000,00€ | 27.33000000 BIO |
Kupite Bio Protocol sigurno
Registrirajte se na Bit2Me i pristupite najpouzdanijoj platformi za razmjenu kriptovaluta za sigurno kupovanje i prodaju Bio Protocol.
Što je Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
